0001209191-23-016778.txt : 20230307
0001209191-23-016778.hdr.sgml : 20230307
20230307163835
ACCESSION NUMBER: 0001209191-23-016778
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160803
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 23713144
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2016-08-03
2016-08-05
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001380187
Abdun-Nabi Daniel
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
0
0
0
Common Stock
41762
D
The number of shares has been adjusted to reflect the correct number of shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016. On March 26, 2020, the Issuer effected a reverse stock split at a ratio of 1-for-14, resulting in every 14 shares owned by the reporting person to be combined into one share of common stock, thus reducing the number of shares owned by the reporting person to 4,173 as of March 26, 2020.
/s/ SoYoung Kwon, Attorney-in-Fact
2023-03-07